Literature DB >> 18987147

VP22 of herpes simplex virus 1 promotes protein synthesis at late times in infection and accumulation of a subset of viral mRNAs at early times in infection.

Carol Duffy1, Ekaette F Mbong, Joel D Baines.   

Abstract

VP22, encoded by the U(L)49 gene, is one of the most abundant proteins of the herpes simplex virus 1 (HSV-1) tegument. In the present study we show VP22 is required for optimal protein synthesis at late times in infection. Specifically, in the absence of VP22, viral proteins accumulated to wild-type levels until approximately 6 h postinfection. At that time, ongoing synthesis of most viral proteins dramatically decreased in the absence of VP22, whereas protein stability was not affected. Of the individual proteins we assayed, VP22 was required for optimal synthesis of the late viral proteins gE and gD and the immediate-early protein ICP0 but did not have discernible effects on accumulation of the immediate-early proteins ICP4 or ICP27. In addition, we found VP22 is required for the accumulation of a subset of mRNAs to wild-type levels at early, but not late, times in infection. Specifically, the presence of VP22 enhanced the accumulation of gE and gD mRNAs until approximately 9 h postinfection, but it had no discernible effect at later times in infection. Also, VP22 did not significantly affect ICP0 mRNA at any time in infection. Thus, the protein synthesis and mRNA phenotypes observed with the U(L)49-null virus are separable with regard to both timing during infection and the genes affected and suggest separate roles for VP22 in enhancing the accumulation of viral proteins and mRNAs. Finally, we show that VP22's effects on protein synthesis and mRNA accumulation occur independently of mutations in genes encoding the VP22-interacting partners VP16 and vhs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18987147      PMCID: PMC2612369          DOI: 10.1128/JVI.02245-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Herpes simplex virus ICP27 protein provides viral mRNAs with access to the cellular mRNA export pathway.

Authors:  M D Koffa; J B Clements; E Izaurralde; S Wadd; S A Wilson; I W Mattaj; S Kuersten
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

2.  Assembly of infectious Herpes simplex virus type 1 virions in the absence of full-length VP22.

Authors:  L E Pomeranz; J A Blaho
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Identification and characterization of a small modular domain in the herpes simplex virus host shutoff protein sufficient for interaction with VP16.

Authors:  J Schmelter; J Knez; J R Smiley; J P Capone
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

4.  The virion host shutoff protein of herpes simplex virus type 1: messenger ribonucleolytic activity in vitro.

Authors:  B D Zelus; R S Stewart; J Ross
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

5.  Herpes simplex virus VP16 rescues viral mRNA from destruction by the virion host shutoff function.

Authors:  Q Lam; C A Smibert; K E Koop; C Lavery; J P Capone; S P Weinheimer; J R Smiley
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

6.  Herpes simplex ICP27 mutant viruses exhibit reduced expression of specific DNA replication genes.

Authors:  S L Uprichard; D M Knipe
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

7.  VP16 interacts via its activation domain with VP22, a tegument protein of herpes simplex virus, and is relocated to a novel macromolecular assembly in coexpressing cells.

Authors:  G Elliott; G Mouzakitis; P O'Hare
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

8.  Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5- mutants of herpes simplex virus 1.

Authors:  J Chou; J J Chen; M Gross; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

9.  Microtubule reorganization during herpes simplex virus type 1 infection facilitates the nuclear localization of VP22, a major virion tegument protein.

Authors:  A Kotsakis; L E Pomeranz; A Blouin; J A Blaho
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

10.  The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase.

Authors:  B He; M Gross; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

View more
  19 in total

1.  Recruitment of herpes simplex virus type 1 immediate-early protein ICP0 to the virus particle.

Authors:  Kevin Maringer; Gillian Elliott
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

2.  Mode of virus rescue determines the acquisition of VHS mutations in VP22-negative herpes simplex virus 1.

Authors:  Katja Ebert; Daniel P Depledge; Judith Breuer; Laura Harman; Gillian Elliott
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

3.  Elucidation of the block to herpes simplex virus egress in the absence of tegument protein UL16 reveals a novel interaction with VP22.

Authors:  Jason L Starkey; Jun Han; Pooja Chadha; Jacob A Marsh; John W Wills
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

4.  Herpes Simplex Virus 1 Tegument Protein VP22 Abrogates cGAS/STING-Mediated Antiviral Innate Immunity.

Authors:  Jian Huang; Hongjuan You; Chenhe Su; Yangxin Li; Shunhua Chen; Chunfu Zheng
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

5.  Varicella-Zoster Virus ORF9p Binding to Cellular Adaptor Protein Complex 1 Is Important for Viral Infectivity.

Authors:  Marielle Lebrun; Julien Lambert; Laura Riva; Nicolas Thelen; Xavier Rambout; Caroline Blondeau; Marc Thiry; Robert Snoeck; Jean-Claude Twizere; Franck Dequiedt; Graciela Andrei; Catherine Sadzot-Delvaux
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

6.  A VP22-Null HSV-1 Is Impaired in Inhibiting CD1d-Mediated Antigen Presentation.

Authors:  Jianyun Liu; Richard M Gallo; Carol Duffy; Randy R Brutkiewicz
Journal:  Viral Immunol       Date:  2016-06-21       Impact factor: 2.257

7.  Herpes simplex virus type 1/adeno-associated virus hybrid vectors.

Authors:  Anna Paula de Oliveira; Cornel Fraefel
Journal:  Open Virol J       Date:  2010-06-18

8.  Purification of full-length VP22 from cells infected with HSV-1: A two-pronged approach for the solubilization and purification of viral proteins for use in biochemical studies.

Authors:  Ebony J Dewberry; Eric Dunkerley; Carol Duffy
Journal:  J Virol Methods       Date:  2012-04-28       Impact factor: 2.014

9.  Deletion of the herpes simplex virus 1 UL49 gene results in mRNA and protein translation defects that are complemented by secondary mutations in UL41.

Authors:  Ekaette F Mbong; Lucille Woodley; Eric Dunkerley; Jane E Schrimpf; Lynda A Morrison; Carol Duffy
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

10.  Herpes Virus Amplicon Vectors.

Authors:  Suresh de Silva; William J Bowers
Journal:  Viruses       Date:  2009-12-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.